FASOLATO, SILVANO
 Distribuzione geografica
Continente #
NA - Nord America 6.350
AS - Asia 4.179
EU - Europa 1.777
SA - Sud America 570
AF - Africa 515
Continente sconosciuto - Info sul continente non disponibili 92
OC - Oceania 45
Totale 13.528
Nazione #
US - Stati Uniti d'America 6.013
SG - Singapore 1.250
VN - Vietnam 862
CN - Cina 706
HK - Hong Kong 410
IT - Italia 384
BR - Brasile 328
DE - Germania 220
FI - Finlandia 160
BD - Bangladesh 139
FR - Francia 138
IN - India 132
SE - Svezia 96
GB - Regno Unito 91
PL - Polonia 89
UA - Ucraina 82
CA - Canada 67
NL - Olanda 58
IQ - Iraq 50
AR - Argentina 48
TR - Turchia 48
JP - Giappone 43
MX - Messico 42
RU - Federazione Russa 42
PH - Filippine 39
TW - Taiwan 39
CO - Colombia 37
SA - Arabia Saudita 35
EC - Ecuador 33
PK - Pakistan 31
AL - Albania 29
CI - Costa d'Avorio 29
ID - Indonesia 29
AT - Austria 27
TH - Thailandia 26
CL - Cile 25
ES - Italia 25
JM - Giamaica 25
VE - Venezuela 24
PE - Perù 23
ZA - Sudafrica 23
IE - Irlanda 22
KR - Corea 22
LB - Libano 21
UZ - Uzbekistan 21
KE - Kenya 20
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
HR - Croazia 19
JO - Giordania 19
MA - Marocco 19
SK - Slovacchia (Repubblica Slovacca) 19
BY - Bielorussia 18
EG - Egitto 18
AZ - Azerbaigian 17
BF - Burkina Faso 17
BO - Bolivia 17
CU - Cuba 17
PA - Panama 17
RO - Romania 17
YE - Yemen 17
BB - Barbados 16
DK - Danimarca 16
IS - Islanda 16
LA - Repubblica Popolare Democratica del Laos 16
LY - Libia 16
PY - Paraguay 16
TZ - Tanzania 16
BA - Bosnia-Erzegovina 15
BS - Bahamas 15
ET - Etiopia 15
GM - Gambi 15
GN - Guinea 15
MY - Malesia 15
NG - Nigeria 15
PS - Palestinian Territory 15
SN - Senegal 15
AU - Australia 14
BW - Botswana 14
CH - Svizzera 14
CW - ???statistics.table.value.countryCode.CW??? 14
DJ - Gibuti 14
EE - Estonia 14
GT - Guatemala 14
MN - Mongolia 14
NP - Nepal 14
PR - Porto Rico 14
RS - Serbia 14
BJ - Benin 13
CD - Congo 13
DZ - Algeria 13
IL - Israele 13
KG - Kirghizistan 13
KH - Cambogia 13
KZ - Kazakistan 13
LV - Lettonia 13
MK - Macedonia 13
SO - Somalia 13
TN - Tunisia 13
TT - Trinidad e Tobago 13
Totale 12.929
Città #
Singapore 765
Ashburn 719
San Jose 696
Fairfield 475
Chandler 425
Hong Kong 369
Woodbridge 319
Ann Arbor 275
Ho Chi Minh City 242
Houston 242
Hanoi 204
Wilmington 176
Cambridge 175
Seattle 172
Santa Clara 155
Jacksonville 154
Beijing 152
Los Angeles 147
Boardman 109
New York 88
Princeton 79
Helsinki 70
Lauterbourg 64
Bytom 63
Council Bluffs 63
Padova 58
Des Moines 57
San Diego 56
Medford 55
Roxbury 52
Da Nang 50
Buffalo 49
Munich 47
Nanjing 42
Dong Ket 33
Haiphong 33
Milan 33
Chicago 32
Tokyo 29
Abidjan 28
Rome 27
Turku 27
Dallas 26
Guangzhou 25
Orem 25
São Paulo 25
Nuremberg 22
Shenyang 22
Tashkent 20
Atlanta 19
Boston 19
Frankfurt am Main 19
Hefei 19
Hải Dương 19
Nairobi 19
Lima 18
London 18
Tirana 18
Amsterdam 17
Baku 17
Dublin 17
Nanchang 17
Can Tho 16
Chennai 16
Stockholm 16
Bridgetown 15
Dakar 15
Dar es Salaam 15
Havana 15
Kaohsiung City 15
Lahore 15
Montreal 15
Nassau 15
Panama City 15
Quito 15
Reykjavik 15
Washington 15
Amman 14
Conakry 14
Hebei 14
Minsk 14
Ouagadougou 14
Phoenix 14
Santiago 14
Toronto 14
Ulan Bator 14
Vienna 14
Vientiane 14
Baghdad 13
Biên Hòa 13
Dearborn 13
Kingston 13
Mexico City 13
Phnom Penh 13
Riga 13
Willemstad 13
Addis Ababa 12
Bangkok 12
Brooklyn 12
Cotonou 12
Totale 8.041
Nome #
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 343
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 341
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 341
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 307
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 299
Ternary Hybrid γ-Fe2O3/CrVI/Amine Oxidase Nanostructure for Electrochemical Sensing: Application for Polyamine Detection in Tumor Tissue 298
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 291
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 287
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 277
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 276
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 273
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 266
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 260
Acute Kidney Injury Network (AKIN) criteria in the detection of renal failure in patients with cirrhosis, ascites and a serum creatinine < 1.5 mg/dl 254
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 252
Terapia diuretica combinata "Ab Initio" versus terapia diuretica sequenziale nel trattamento dell'ascite moderata in pazienti con cirrosi epatica senza insufficienza renale 251
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 250
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 250
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 243
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 241
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 241
Endoscopic diode laser therapy for gastric hyperplastic polyps in cirrhotic patients 240
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 239
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial 237
Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study. 232
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma 231
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 228
Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial 225
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure 225
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 217
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin 211
Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial. 205
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 203
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 201
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 197
The Treatment of Hepatorenal Syndrome 195
Effetti sull’emodinamica splancnica e sulla circolazione sistemica della somministrazione acuta di un inibitore specifico della ossido nitrico sintetasi inducibile 181
Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds 177
Increased urinary level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS. 175
Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical study 172
Il ruolo dei peptidi natriuretici endogeni negli stati sodioritentivi 170
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites 170
Comparison between nifedipine and carvedilol in the treatment of “de novo” arterial hypertension after liver transplantation (LT): preliminary results of a controlled clinical trial 169
Bacterial infections in cirrhosis: epidemiology and prevalence of antibiotic resistence, a restrospective monocentric study 164
Working Memory in Patients with Varying Degree of Hepatic Encephalopathy (HE): A Pilot EEG-fNIRS Study 162
Cardiac dysfunction in patients with cirrhosis: is the systolic component its main feature? PMID: 25923940 162
Il valore predittivo della clearance del litio sulle complicanze ascite correlate 161
Iron oxide-chromate core-shell nanostructure for the electrochemical biosensing of polyamines in liver cancer tissues 161
Monoclonal Gammopathy of Undetermined Significance (MGUS) after Liver Transplantation: A Risk Factor for Long-Term Medical Complications Other Than Malignancy 153
Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers 151
Moderate dietary sodium restriction in outpatients with cirrhosis and ascites iIn the real life: adherence and more 148
Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene. 145
INCREASED URINARY LEVEL OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN PATIENTS WITH CIRRHOSIS AND TYPE 1 HRS 143
Sequential versus “ab initio” combined diuretic tretament of moderate ascites in cirrhotic patients: final results of a randomized controlled multicenter clinical study. 132
La inhibicion selectiva de la sintasa inducibile del oxido nitrico (iNOS) reduce la vasodilatacion esplancnica en ratas cirrhoticas con ascitis 123
La peritonite batterica spontanea 119
L’ epatite da virus C dopo trapianto di fegato: storia naturale e prospettive di prevenzione e terapia 115
La inhibicion selectiva de la sintasa inducibile del oxido nitrico (iNOS) reduce la vasodilatacion esplancnica en ratas cirrhoticas con ascitis 114
Le infezioni batteriche nel paziente cirrotico con ascite 112
Terlipressin given as i.v. boluses vs terlipressin given as continuous intravenous infusion in patients with cirrhosis and type 1 hepatorenal sindrome(HRS): prelimnary results of a randomized controlled clinical study. 110
Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma 105
La sindrome epatorenale(SER) 104
La recidiva dell’epatite da HCV nel post-trapianto: epidemiologia e trattamento 103
Terlipressin and albumin vs midodrine plus octretide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a trial by the Italian Association for the study of the liver. 89
Prevalenza del DNA batterico in pazienti con cirrosi e ascite refrattaria ed il suo ruolo nello sviluppo di disfunzioni renali e cardiovascolari 89
Rischio cardiovascolare ed ipertensione arteriosa dopo trapianto di fegato 87
Temporal relatioship between systemic and splanchnic vasodilation,Nos activity and ascites formation in cirrhotic rats. 82
TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 81
Prevalence of bacterial DNA in patients with cirrhosis and refractory ascites and its role in the development of cardiac and renal dysfunctions 72
Totale 13.528
Categoria #
all - tutte 37.507
article - articoli 29.444
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 124 77 58 42 44 26 78 27 27 56 191
2022/2023825 153 93 14 110 116 124 8 54 104 5 38 6
2023/2024431 20 56 62 41 29 71 27 33 8 11 31 42
2024/20251.851 11 148 94 100 194 78 81 133 147 74 326 465
2025/20266.894 308 492 794 861 670 291 1.326 559 722 417 270 184
2026/2027362 248 114 0 0 0 0 0 0 0 0 0 0
Totale 13.528